| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.21 | 9e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |